Physion has appointed JS Consulting as their strategic advisor for the GCC & Middle East regions.
JS Consulting is delighted to announce it will be working with Physion s.r.l of Italy to advise on the company’s expansion in the Middle East and Gulf regions.
The two organisations have successfully worked together for several years in the United Kingdom, with JS Medical (previously known as Jump Start Consulting Limited) representing Physion as the UK distributor for the EMDA® (ElectroMotive Drug Administration) range of medical devices and products.
Following the success of our collaboration in the UK market and the enormous experience of the JS Consulting team in the Middle East and GCC countries, we feel the team are our ideal partner to develop our presence in these territories.
Paulo Eruzzi, CEO at Physion.
Headquartered in Italy, Physion manufactures the EMDA® range of medical devices used to treat urological conditions including non-muscle invasive bladder cancer, recurrent and persistent UTI and interstitial cystitis.
Our network of specialists and key opinion leaders throughout the MENA region was key to Physion’s decision to appoint JS Consulting. We are looking forward to working with Paulo Eruzzi and his team to generate new distribution opportunities and raise the company’s profile.
Murat Celebi, Director Clinical Marketing at JS Consulting
Distributors interested in representing Physion in these regions should contact Murat Celebi or Catriona Riley, Operations Director, on +44 ()1234-888955 or by email via email@example.com.
Physion s.r.l. is based in Mirandola, Italy, and manufactures highly innovative and efficient therapeutic products and models for the treatment of bladder cancer, functional bladder diseases, Peyronie’s disease and Scheletal Muscle pathologies.